Search results
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Integrated Advisors Network LLC
ETF DAILY NEWS· 2 days agoIntegrated Advisors Network LLC cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by ...
Kapitalo Investimentos Ltda Purchases 130 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 3 days agoKapitalo Investimentos Ltda increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) ...
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 52-Week High Following Analyst Upgrade
ETF DAILY NEWS· 4 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week high during mid-day trading ...
...Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN - Regeneron...
Benzinga· 7 days agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc
Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
TipRanks via Yahoo Finance· 1 day agoRegeneron (NASDAQ:REGN) stock has more than tripled in value in the past five years, with the price...
Regeneron director Brown sells shares worth over $1.5 million By Investing.com
Investing.com· 4 days agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) Director Michael S. Brown has completed...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 3 days agoBiotech giant Regeneron Pharmaceuticals REGN is one of the few top biotech companies that has...
Teva and DOJ May Reach Settlement in Closely Watched AKS Lawsuit
The National Law Review· 9 hours agoOn June 16, Teva Pharmaceuticals filed a request with the First Circuit Court of Appeals seeking to...
Equities Research Analysts’ Price Target Changes for June 17th (ACN, AMAT, AMH, ARM, ASML, AVB,...
ETF DAILY NEWS· 4 days agoEquities Research Analysts’ price target changes for Monday, June 17th: Accenture (NYSE:ACN) had its...
Biotech startup raises $190 million to focus on new approach to heart attack, stroke and more - San...
The Business Journals· 4 days agoA serial biotech entrepreneur, a longtime UCSF researcher, a shelved Big Pharma drug and $190...